Evidence map›Paper›PMID 25339205›Full record

ArticleMolecular carcinogenesis2015

Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study.

Avonne E Connor, Richard N Baumgartner, Kathy B Baumgartner, Christina M Pinkston, Stephanie D Boone, Esther M John, Gabriela Torres-Mejía, Lisa M Hines, Anna R Giuliano, Roger K Wolff and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular carcinogenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genetic Variants inFrontiers in oncology · 2021
    Article
  7. Observational
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Genomic Disparities in Breast Cancer Among Latinas.Cancer control : journal of the Moffitt Cancer Center · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Avonne E ConnorDepartment of Epidemiology and Population Health, School of Public Health and Information Sciences, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky.
Richard N BaumgartnerDepartment of Epidemiology and Population Health, School of Public Health and Information Sciences, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky.
Kathy B BaumgartnerDepartment of Epidemiology and Population Health, School of Public Health and Information Sciences, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky.
Christina M PinkstonDepartment of Epidemiology and Population Health, School of Public Health and Information Sciences, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky.
Stephanie D BooneDepartment of Epidemiology and Population Health, School of Public Health and Information Sciences, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky.
Esther M JohnCancer Prevention Institute of California, Fremont, California.
Gabriela Torres-MejíaInstituto Nacional de Salud Pública, Centro de Investigación en Salud Poblacional, Cuernavaca, Morelos, Mexico.
Lisa M HinesDepartment of Biology, University of Colorado Colorado Springs, Colorado Springs, Colorado.
Anna R GiulianoH. Lee Moffit Cancer Center & Research Institute, Tampa, Florida.
Roger K WolffDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Martha L SlatteryDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
University of Louisville · USUniversity of Utah · USCancer Prevention Institute of California · USInstituto Nacional de Salud Pública · MXMoffitt Cancer Center · USUniversity of Colorado Colorado Springs · US

Funding

CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
FOUR-CORNERS BREAST AND ENDOMETRIAL CANCER STUDYR01CA078682 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA OR MARTY L · 1999 to 2003
$4.0M
Disparities in Breast Cancer: Development and Survival in Hispanic and NHW WomenR01CA140002 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA L · 2009 to 2013
$3.1M
THE 4 CORNERS BREAST AND ENDOMETRIAL CANCER STUDYR01CA078762 · NCI · UNIVERSITY OF NEW MEXICO · PI BAUMGARTNER, KATHY B · 1999 to 2003
$3.0M
FOUR-CORNERS BREAST AND ENDOMETRIAL CANCER STUDYR01CA078802 · NCI · UNIVERSITY OF ARIZONA · PI MARTINEZ, MARIA ELENA · 1999 to 2003
$2.2M
FOUR-CORNERS BREAST CANCER STUDYR01CA078552 · NCI · UNIVERSITY OF COLORADO DENVER · PI BYERS, TIM E · 1999 to 2003
$1.5M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067000 · PC · UNIVERSITY OF UTAH · PI WIGGINS, CHARLES L · 1996 to 2000
$1.3M
VITAMIN D RECEPTOR GENE POLYMORPHISM AND BREAST CANCERR01CA077305 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M · 1999 to 2001
$834k
BREAST CANCER RISK FACTORS IN HISPANIC WOMENR01CA063446 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M · 1995 to 1998
–
NCCDPHP CDC HHS 1U58 DP000807-01NCCDPHP CDC HHS U58 DP000807NCI NIH HHS CA14002NCI NIH HHS CA77305NCI NIH HHS HHSN261201000036CNCI NIH HHS N01-PC-67000NCI NIH HHS R01 CA063446NCI NIH HHS R01 CA078552NCI NIH HHS R01 CA078682NCI NIH HHS R01 CA078762NCI NIH HHS R01 CA078802NCI NIH HHS R01 CA140002PHS HHS HHSN261201000036C
6 · The paper itself

Abstract

Chronic inflammation is suggested to be associated with specific cancer sites, including breast cancer. Recent research has focused on the roles of genes involved in the leukotriene/lipoxygenase and prostaglandin/cyclooxygenase pathways in breast cancer etiology. We hypothesized that genes in ALOX/COX pathways and CRP polymorphisms would be associated with breast cancer risk and mortality in our sample of Hispanic/Native American (NA) (1430 cases, 1599 controls) and non-Hispanic white (NHW) (2093 cases, 2610 controls) women. A total of 104 Ancestral Informative Markers was used to distinguish European and NA ancestry. The adaptive rank truncated product (ARTP) method was used to determine the significance of associations for each gene and the inflammation pathway with breast cancer risk and by NA ancestry. Overall, the pathway was associated with breast cancer risk (PARTP = 0.01). Two-way interactions with NA ancestry (P(adj)  < 0.05) were observed for ALOX12 (rs2292350, rs2271316) and PTGS1 (rs10306194). We observed increases in breast cancer risk in stratified analyses by tertiles of polyunsaturated fat intake for ALOX12 polymorphisms; the largest increase in risk was among women in the highest tertile with ALOX12 rs9904779CC (Odds Ratio (OR), 1.49; 95% Confidence Interval (CI) 1.14-1.94, P(adj) = 0.01). In a sub-analysis stratified by NSAIDs use, two-way interactions with NSAIDs use were found for ALOX12 rs9904779 (P(adj)  = 0.02), rs434473 (P(adj ) = 0.02), and rs1126667 (P(adj)  =  0.01); ORs for ALOX12 polymorphisms ranged from 1.55 to 1.64 among regular users. Associations were not observed with breast cancer mortality. These findings could support advances in the discovery of new pathways related to inflammation for breast cancer treatment.

Indexed as

AdultAgedArachidonate 12-LipoxygenaseBreast NeoplasmsCase-Control StudiesC-Reactive ProteinEthnicityFemaleGenetic Predisposition to DiseaseGenotypeHealthcare DisparitiesHispanic or LatinoHumansMiddle AgedOdds RatioPolymorphism, GeneticALOX12 protein, humanArachidonate 12-LipoxygenaseC-Reactive ProteinProstaglandin-Endoperoxide Synthaseschronic inflammationethnicitygenetic variants

Identifiers

PMID25339205
PMCPMC4406776
OpenAlexW1941361792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.